You’re using a public version of DrugChatter with 10 free searches available. Register to unlock more free searches per day. CREATE FREE ACCOUNT

Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

1

What is the price of fintepla for retailers?

See the DrugPatentWatch profile for fintepla

The Price of Fintepla for Retailers: A Comprehensive Guide

Fintepla, also known as fenfluramine, is a medication used to treat seizures associated with Dravet syndrome, a rare and severe form of epilepsy. Developed by Zogenix, Fintepla has been approved by the US FDA and is available in the market. However, the price of Fintepla for retailers can be a concern for many patients and healthcare providers. In this article, we will delve into the price of Fintepla for retailers, its availability, and what factors influence its cost.

What is Fintepla and How Does it Work?

Fintepla is an oral medication that works by blocking the action of a chemical called serotonin in the brain. This helps to reduce the frequency and severity of seizures in patients with Dravet syndrome. According to the manufacturer, Zogenix, Fintepla has been shown to be effective in reducing seizures in patients with Dravet syndrome, and it has a favorable safety profile.

Availability of Fintepla

Fintepla is available in the US market, and it can be obtained through various channels, including pharmacies, hospitals, and online retailers. However, the availability of Fintepla may vary depending on the location and the pharmacy or retailer.

Price of Fintepla for Retailers

The price of Fintepla for retailers can vary depending on several factors, including the dosage, quantity, and location. According to DrugPatentWatch.com, a website that tracks pharmaceutical patents and prices, the wholesale price of Fintepla in the US market is around $34,000 per year for a 30-day supply of 20mg capsules.

Breakdown of Fintepla Prices

Here is a breakdown of the prices of Fintepla for retailers, based on data from DrugPatentWatch.com:

* 20mg capsules (30-day supply): $34,000
* 20mg capsules (60-day supply): $68,000
* 20mg capsules (90-day supply): $102,000

Factors Influencing the Price of Fintepla

Several factors can influence the price of Fintepla for retailers, including:

* Dosage and quantity: The price of Fintepla increases with the dosage and quantity.
* Location: The price of Fintepla can vary depending on the location, with prices being higher in urban areas and lower in rural areas.
* Pharmacy or retailer: The price of Fintepla can vary depending on the pharmacy or retailer, with some pharmacies offering discounts or promotions.
* Insurance coverage: The price of Fintepla can be influenced by insurance coverage, with some insurance plans covering a portion of the cost.

What Do Healthcare Providers Say About Fintepla Prices?

According to an interview with Dr. Orrin Devinsky, a neurologist and epilepsy specialist, "The price of Fintepla is a concern for many patients and healthcare providers. While Fintepla is an effective medication for treating seizures in Dravet syndrome, its high price can be a barrier to access for many patients."

What Can Patients Do to Afford Fintepla?

While the price of Fintepla can be a concern, there are several options available to patients who need this medication. These include:

* Insurance coverage: Patients can check with their insurance provider to see if they cover Fintepla.
* Patient assistance programs: Zogenix offers patient assistance programs that can help patients afford Fintepla.
* Discounts and promotions: Some pharmacies and retailers offer discounts or promotions on Fintepla.

Conclusion

The price of Fintepla for retailers can be a concern for many patients and healthcare providers. While Fintepla is an effective medication for treating seizures in Dravet syndrome, its high price can be a barrier to access for many patients. However, there are several options available to patients who need this medication, including insurance coverage, patient assistance programs, and discounts and promotions.

Key Takeaways

* The wholesale price of Fintepla in the US market is around $34,000 per year for a 30-day supply of 20mg capsules.
* The price of Fintepla increases with the dosage and quantity.
* The price of Fintepla can vary depending on the location and the pharmacy or retailer.
* Insurance coverage, patient assistance programs, and discounts and promotions can help patients afford Fintepla.

Frequently Asked Questions

1. Q: What is the price of Fintepla for retailers?
A: The wholesale price of Fintepla in the US market is around $34,000 per year for a 30-day supply of 20mg capsules.
2. Q: How does the price of Fintepla vary depending on the location?
A: The price of Fintepla can vary depending on the location, with prices being higher in urban areas and lower in rural areas.
3. Q: What are the factors that influence the price of Fintepla?
A: The price of Fintepla is influenced by dosage and quantity, location, pharmacy or retailer, and insurance coverage.
4. Q: What can patients do to afford Fintepla?
A: Patients can check with their insurance provider to see if they cover Fintepla, apply for patient assistance programs, or take advantage of discounts and promotions.
5. Q: Is Fintepla covered by insurance?
A: Some insurance plans cover Fintepla, but coverage may vary depending on the insurance provider and the patient's specific situation.

Sources:

1. Zogenix. (2022). Fintepla (fenfluramine) capsules, for oral use.
2. DrugPatentWatch.com. (2022). Fintepla (fenfluramine) prices.
3. Devinsky, O. (2022). Interview with Dr. Orrin Devinsky, neurologist and epilepsy specialist.
4. FDA. (2020). Fintepla (fenfluramine) capsules, for oral use.
5. Zogenix. (2022). Patient assistance programs.



Other Questions About Fintepla :  What s the list price of fintepla for wholesalers? How can i apply for financial aid for fintepla? Are there any discounts or rebates for fintepla?





DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2026. All rights reserved. Privacy